CN106039113A - Traditional Chinese medicine prescription for treating gout - Google Patents
Traditional Chinese medicine prescription for treating gout Download PDFInfo
- Publication number
- CN106039113A CN106039113A CN201610558961.3A CN201610558961A CN106039113A CN 106039113 A CN106039113 A CN 106039113A CN 201610558961 A CN201610558961 A CN 201610558961A CN 106039113 A CN106039113 A CN 106039113A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- prescription
- rhizoma
- cortex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 201000005569 Gout Diseases 0.000 title claims abstract description 21
- 241000255791 Bombyx Species 0.000 claims abstract description 13
- 210000004369 blood Anatomy 0.000 claims abstract description 13
- 239000008280 blood Substances 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 11
- 241000005787 Cistanche Species 0.000 claims abstract description 7
- 241000628997 Flos Species 0.000 claims abstract description 7
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 7
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims abstract description 7
- 241000903946 Clematidis Species 0.000 claims abstract description 6
- 235000019510 Long pepper Nutrition 0.000 claims abstract description 6
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 6
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 6
- 240000003455 Piper longum Species 0.000 claims abstract description 6
- 241000131808 Scolopendra Species 0.000 claims abstract description 6
- 210000000582 semen Anatomy 0.000 claims abstract description 6
- 239000009636 Huang Qi Substances 0.000 claims abstract description 4
- 238000011282 treatment Methods 0.000 claims description 13
- 241001494479 Pecora Species 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 230000008961 swelling Effects 0.000 claims description 5
- 244000025254 Cannabis sativa Species 0.000 claims description 4
- 239000002390 adhesive tape Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 240000007171 Imperata cylindrica Species 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 229940126532 prescription medicine Drugs 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000405217 Viola <butterfly> Species 0.000 claims 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 15
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 15
- 229940116269 uric acid Drugs 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 10
- 238000001816 cooling Methods 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 241000282817 Bovidae Species 0.000 abstract description 2
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000927897 Lycopodium japonicum Species 0.000 abstract 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 1
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 210000001367 artery Anatomy 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 231100000862 numbness Toxicity 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 229910052938 sodium sulfate Inorganic materials 0.000 abstract 1
- 235000011152 sodium sulphate Nutrition 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 210000003462 vein Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 210000001503 joint Anatomy 0.000 description 3
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010018634 Gouty Arthritis Diseases 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 229960002009 naproxen Drugs 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000035977 Rare disease Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- HFHZKZSRXITVMK-UHFFFAOYSA-N oxyphenbutazone Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 HFHZKZSRXITVMK-UHFFFAOYSA-N 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine prescription for treating gout. The traditional Chinese medicine prescription is composed of an oral prescription and an external prescription, wherein the oral prescription is prepared from antelope bone, cornu bubali, cortex lycii radicis, gypsum fibrosum, mori ramulus vetus, rhizoma imperatae, semen coicis, cortex sclerotii poriae, radix clematidis, scolopendra, flos carthami, radix et rhizoma rhei, radix astragali, cortex moutan radicis, squama manitis, jujube peel, radix remanniae, radix salviae miltiorrhizae, bombyx batryticatus, herba cistanches and herba epimedii acuminate; the external prescription is prepared from radix notoginseng powder, radix et rhizoma rhei, piper longum, Lycopodium jaPonicum Thunb., bombyx batryticatus, sodium sulfate, rhizoma pinellinae praeparata, arisacma consanguineum schott, venenum bufonis, leech and herba violae. The traditional Chinese medicine prescription mainly has effects of clearing and activating channels and collaterals, promoting the circulation of qi and blood, eliminating dampness and pain or numbness, tonifying kidney and strengthening bones, has beneficial effects of clearing heat and cooling blood, optimizing bones and refreshing arteries and veins, and inhibiting uric acid, and has a cure rate up to 80% and an effective rate up to 100%.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition and preparation method thereof, particularly relate in a kind for the treatment of gout
Medicine prescription.
Background technology
Gout is that the metabolism of purine substance gets muddled in human body, causes the synthesis of Uric Acid to increase or discharge and subtracts
Few, cause hyperuricemia, when human body serum Uric Acid Concentration is too high, uric acid is deposited on joint, cartilage and kidney with the form of sodium salt
In dirty, cause tissue foreign body inflammatory reaction, i.e. gout.Gout is developed into present commonly encountered diseases, same people by rare disease previously
Dietary habit, lifestyle change closely related.Its clinical characters is acute gouty arthritis and the hematuria of recurrent exerbation
Acid is increased.Acute stage most of patients, in midnight or onset in early morning, is that the first sole of the foot toe closes from the beginning of mostly being single Joint Inflammation, about half
Secondly joint, instep, often involve heel, toe articulations digitorum manus and other medium and small joints, affected joints red and swollen heat pain, and with heating, in vain
Cell increases, and erythrocyte sedimentation rate accelerates, and night, often severe pain not able person slept, and about after several weeks, symptom gradually disappears, and sends out after several months or several years again,
Proceed to chronic phase, cause arthroncus deformity, stiff.Just treatment during major part patient with gout outbreak, does not the most pay attention to,
Due to its medical history length, recurrent exerbation, present a kind of lifelong participation disease form.Blood uric acid raises in fact, not only can cause urgency
The arthritic outbreak of property, also can cause the important organ such as heart, kidney to damage, therefore actively the controlling of acute attack stage to be paid attention to
Treat, also to pay attention to paracmastic treatment, carry out well and can greatly reduce gouty arthritis outbreak, delay disease progression, prevent
Complication.
The Western medicine being currently used for treating gout mainly has: colchicine, Phenylbutazone or crovaril, indometacin, cloth
Ibuprofen (ibvprofen, ibuprofen), piroxicam (piroxicanum), naproxen (naproxen congex
), ACTH and prednisone etc..But said medicine can only stablize the state of an illness mostly, can not effect a radical cure gout；Also can cause serious
Side effect causes the infringement of hepatic and renal function;Even if Emergent therapy effectively can not recur by symptom management, and can produce resistance to
The property of medicine and repellence, even there will be leukopenia, cardiac function is impaired, hepatic and renal function is impaired, stimulating intestine and stomach system,
Aplastic anemia, cause the complication such as diabetes.Increasing expert thinks: from the organic conception of the traditional Chinese medical science,
Treat with Chinese medicine integral syndrome differentiation, the good footpath of another bar for the treatment of gout of can yet be regarded as；Not only the poison of Chinese medicine itself is secondary makees
With greatly reducing, and Western medicine dose can be reduced, overcome and take merely the huge toxic and side effects that Western medicine is brought for a long time.
But the Chinese patent medicine treating gout in the market is few, and curative effect is the most more a lack of, and patient still can only be by taking poison in a large number
The state of an illness stablized by the Western medicine that side effect is bigger.
Summary of the invention
The present invention provides a kind of clearing away heat and cooling blood, the Chinese medicine composition of the suitable fresh wheat of bone.
A kind of Chinese prescription for treating gout, is taken orally prescription by one and external application prescription forms, prescription compatibility for oral administration
For: Os Caprae Saigae Tataricae, Cornu Bubali, Cortex Lycii Gypsum Fibrosum, old Ramulus Mori, Rhizoma Imperatae, Semen Coicis, Cortex Sclerotii Poriae, Radix Clematidis, Scolopendra, Flos Carthami,
Radix Et Rhizoma Rhei, the Radix Astragali, Cortex Moutan, big gun first, Fructus Corni, the Radix Rehmanniae, Radix Salviae Miltiorrhizae, Bombyx Batryticatus, Herba Cistanches, sheep are suddenly；
External application prescription compatibility is: Radix Notoginseng powder, Radix Et Rhizoma Rhei, Piper longum, tight grass, Bombyx Batryticatus, Matrii Sulfas Exsiccatus, Rhizoma Pinelliae Preparatum, Rhizoma Arisaematis, Venenum Bufonis, blood
, Herba Violae.
Further, above-mentioned prescription quality for oral administration by part compatibility is: Os Caprae Saigae Tataricae 30 parts of Cortex Lycii 30 of 20 parts of Cornu Bubalis
Part 30 parts of Semen Coiciss of 30 parts of Rhizoma Imperataes of the old Ramulus Mori of Gypsum Fibrosum 30 parts, 30 parts of Radix Clematidis of 30 parts of Cortex Sclerotii Poriae 30 parts
20 parts of big gun first of 30 parts of Cortex Moutans of 20 parts of Radixs Astragali of 20 parts of Radix Et Rhizoma Rhei of 10 parts of Flos Carthamis of Scolopendra, 20 parts of Radix Rehmanniae 30 of 20 parts of Fructus Cornis
Part 20 parts of Bombyx Batryticatus of Radix Salviae Miltiorrhizae, 20 portions of sheep of 10 parts of Herba Cistanches 30 parts suddenly.
Further, above-mentioned external application prescription quality by part compatibility is: Radix Notoginseng powder 20 parts of Piper longums of 30 parts of Radix Et Rhizoma Rhei 20 parts
Tight grass 10 parts of ground of 1 part of blood of 15 parts of Venenum Bufoniss of 20 parts of Rhizoma Arisaematis of 10 parts of Rhizoma Pinelliae Preparatum of 20 parts of Matrii Sulfas Exsiccatus of 20 parts of Bombyx Batryticatus
Fourth 6 parts.
Further, the above-mentioned above medicine of prescription Chinese prescription for oral administration grinds into pole not；Make with the adjuvant pharmaceutically accepted
Granule, capsule, tablet, oral liquid, pill or powder；
Above-mentioned external application prescription Chinese prescription medicine grinds does not bottles standby for pole, spreads on congestion and swelling pain with Mel furnishing pasty state during use
Place, gauze immobilization with adhesive tape；Once a day, within 20 days, it is a course for the treatment of.
Cure mainly: gout
Effect: dispelling wind is dispelled bitterly, cool blood and remove dampness eliminates uric acid.
Monarch drug is with Os Caprae Saigae Tataricae Cornu Bubali Rhizoma Imperatae Cortex Lycii Gypsum Fibrosum Radix Clematidis；
Ministerial drug is with old Ramulus Mori Semen Coicis Cortex Sclerotii Poriae big gun first；
Adjuvant drug is with Flos Carthami Radix Et Rhizoma Rhei Cortex Moutan Radix Rehmanniae milkvitch-red sage；
Make medicine with Bombyx Batryticatus Herba Cistanches sheep Fructus Corni suddenly.
Above prescription Orally taken and externally, is a kind of special antipodagric combination, has clearing away heat and cooling blood, and the suitable fresh wheat of bone suppresses uric acid,
Cure rate is up to 80%；Obvious effective rate reaches 100%.
Detailed description of the invention
The present invention is further illustrated below by way of specific embodiment.But the detail of embodiment is only used for explaining this
Bright, it should not be construed as limited overall technical solution.
Embodiment 1
For oral administration: antelope angle dissipates
Os Caprae Saigae Tataricae 20g Cornu Bubali 30g Cortex Lycii 30g Gypsum Fibrosum 30g old Ramulus Mori 30g Rhizoma Imperatae 30g Semen Coicis
5 Flos Carthami 20g Radix Et Rhizoma Rhei 20g Radix Astragali 30g Cortex Moutan 20g big gun first of 30g Cortex Sclerotii Poriae 30g Radix Clematidis 30g Scolopendra
20g Fructus Corni 20g Radix Rehmanniae 30g Radix Salviae Miltiorrhizae 20g Bombyx Batryticatus 10g Herba Cistanches 20g sheep 30g suddenly
Above medicine grinds into pole not.Powder, pill, glue are assisted, powder, medicated wine.
Cure mainly: gout
Effect: dispelling wind is dispelled bitterly, cool blood and remove dampness eliminates uric acid.
External: resuscitation powder
Prescription: Radix Notoginseng powder 30g Radix Et Rhizoma Rhei 20g Piper longum 20g tightly grass 20g Bombyx Batryticatus 20g Matrii Sulfas Exsiccatus 10g Rhizoma Pinelliae Preparatum 20g
Rhizoma Arisaematis 15g Venenum Bufonis 1g blood 10g Herba Violae 6g
Above medicine grinds does not bottles standby for pole, spreads at congestion and swelling pain with Mel furnishing pasty state during use, gauze immobilization with adhesive tape,
Once a day, within 20 days, it is a course for the treatment of.
Above prescription Orally taken and externally, is a kind of special antipodagric combination, has clearing away heat and cooling blood, and the suitable fresh wheat of bone suppresses uric acid,
Effective percentage is 100%, and cure rate is up to 80%.
One, clinical scale: (mainly dividing light, weight two-stage with painful area)
Light: diseased region only has at one, do not involve elsewhere, the course of disease is short, just can take a turn for the better and alleviate once treatment.
Weight: sick three, become position at two more than, the course of disease is longer, and the best through long-term treatment effects.
Clinical efficacy evaluation criteria:
Clinical recovery: red, swollen, pain is wholly absent, and uric acid is corrected, follows up a case by regular visits to more than 1 year not recur.
Effective: redness disappears, also contact pain or walking pain.
Effective: red, swollen, pain significantly disappears, but sense of also swelling and ache.
Invalid: there is no any effect through treatment, and have and increase the weight of trend.
Four, therapeutic outcome: treat three courses for the treatment of by above scheme, treat 72 examples, wherein cure rate 82% altogether, effectively
Rate 100%.
Model case 1
Patient with gout, man 32 years old, the shortest 3 years of the course of disease, uric acid is too high, and redness and swelling of joints deforms, and hurt like hell, lower limb there will be
Lower ground difficulty, simultaneously occurs at upper limb behavior inconvenience, and clinical symptoms is heavier.
Wherein after 5 days, uric acid falls after rise, and redness disappears, also contact pain or walking pain；Red, swollen, pain after two courses for the treatment of
Pain is wholly absent, and uric acid is corrected, and follows up a case by regular visits to more than 1 year not recur.
Model case 2
Patient with gout, female 45 years old, the course of disease 1 year, uric acid is higher, and lower limb are red and swollen, pain, clinical symptoms weight.
Wherein 5 days, uric acid was corrected, and redness disappears, and walking pain, red, swollen after two courses for the treatment of, pain is wholly absent, and follows up a case by regular visits to one
Year is above accidental.
Model case 2
Patient with gout, man 65 years old, the course of disease 2 years, upper limb inconvenience, red and swollen, pain.
Wherein 3 days, redness disappeared, and pain disappears, and red, swollen after 10 day course for the treatment of, pain is wholly absent, and can walk convenient as just
Ordinary person.
Component of the present invention is by weight gram as compatibility, can increase according to corresponding proportion when producing or reduce, as greatly
Large-scale production can by kilogram in units of, or in units of ton, small-scale production can also be in units of milligram, and weight can increase
Big or reduce, but the constant rate of the raw medicinal herbs weight proportion between each composition.
Claims (4)
1. for treating a Chinese prescription for gout, one take prescription orally and external application prescription forms, it is characterised in that institute
Stating prescription compatibility for oral administration is: Os Caprae Saigae Tataricae, Cornu Bubali, Cortex Lycii Gypsum Fibrosum, old Ramulus Mori, Rhizoma Imperatae, Semen Coicis, Cortex Sclerotii Poriae, Wheeling
Celestial being, Scolopendra, Flos Carthami, Radix Et Rhizoma Rhei, the Radix Astragali, Cortex Moutan, big gun first, Fructus Corni, the Radix Rehmanniae, Radix Salviae Miltiorrhizae, Bombyx Batryticatus, Herba Cistanches, sheep are suddenly；
Described external application prescription compatibility is: Radix Notoginseng powder, Radix Et Rhizoma Rhei, Piper longum, tight grass, Bombyx Batryticatus, Matrii Sulfas Exsiccatus, Rhizoma Pinelliae Preparatum, Rhizoma Arisaematis, Venenum Bufonis,
Blood, Herba Violae.
2. Chinese medicine composition as claimed in claim 1, it is characterised in that described prescription quality for oral administration by part compatibility is: Saigae Tataricae
20 parts of Cornu Bubalis of bone, 30 parts of Gypsum Fibrosum of 30 parts of Cortex Lycii, 30 parts of old Ramulus Moris, 30 parts of Semen Coiciss 30 of 30 parts of Rhizoma Imperataes
Part 20 parts of Radix Et Rhizoma Rhei of 10 parts of Flos Carthamis of 30 parts of Scolopendras of 30 parts of Radix Clematidis of Cortex Sclerotii Poriae, 30 parts of Cortex Moutans of 20 parts of Radixs Astragali 20 parts
20 parts of Bombyx Batryticatus of 30 parts of Radix Salviae Miltiorrhizaes of 20 parts of Radix Rehmanniae of 20 parts of Fructus Cornis of big gun first, 20 portions of sheep of 10 parts of Herba Cistanches 30 parts suddenly.
3. Chinese medicine composition as claimed in claim 1 or 2, it is characterised in that described external application prescription quality by part compatibility is:
20 parts of tight careless 20 parts of Bombyx Batryticatus 10 parts of Rhizoma Pinelliae Preparatum of 20 parts of Matrii Sulfas Exsiccatus of Radix Notoginseng powder 20 parts of Piper longums of 30 parts of Radix Et Rhizoma Rhei 20 parts
15 parts of Venenum Bufoniss of Rhizoma Arisaematis, 10 portions of Herba Violaes of 1 part of blood 6 parts.
4. Chinese medicine composition as claimed in claim 1 or 2, it is characterised in that the described above medicine of prescription Chinese prescription for oral administration
Grind for pole not；Granule, capsule, tablet, oral liquid, pill or powder is made with the adjuvant pharmaceutically accepted；
Described external application prescription Chinese prescription medicine grinds does not bottles standby for pole, spreads on congestion and swelling pain with Mel furnishing pasty state during use
Place, gauze immobilization with adhesive tape；Once a day, within 20 days, it is a course for the treatment of.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610558961.3A CN106039113A (en) | 2016-07-17 | 2016-07-17 | Traditional Chinese medicine prescription for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610558961.3A CN106039113A (en) | 2016-07-17 | 2016-07-17 | Traditional Chinese medicine prescription for treating gout |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106039113A true CN106039113A (en) | 2016-10-26 |
Family
ID=57187554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610558961.3A Pending CN106039113A (en) | 2016-07-17 | 2016-07-17 | Traditional Chinese medicine prescription for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106039113A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107375769A (en) * | 2017-08-15 | 2017-11-24 | 徐琛 | A kind of Chinese prescription for being used to treat synovitis |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593589A (en) * | 2004-06-28 | 2005-03-16 | 黄资源 | Gout treating pills and preparation method thereof |
| CN1814220A (en) * | 2005-11-23 | 2006-08-09 | 安徽省药物研究所 | Medicine for treating gout and preparing method |
| CN101347605A (en) * | 2008-08-15 | 2009-01-21 | 北京和润创新医药科技发展有限公司 | Chinese medicinal composition for treating gout and preparation method and application thereof |
| CN101732498A (en) * | 2008-11-17 | 2010-06-16 | 任风辉 | Formula of Chinese medicament for treating gout |
| CN101843867A (en) * | 2009-11-04 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating gout |
| CN102614431A (en) * | 2012-04-21 | 2012-08-01 | 韩合旭 | Medicament for treating gout and bone disease |
| CN102652810A (en) * | 2012-04-12 | 2012-09-05 | 王伟 | Traditional Chinese medicine composition for treating gout and preparation method of traditional Chinese medicine composition |
| CN103007079A (en) * | 2012-12-08 | 2013-04-03 | 张道荣 | Chinese patent medicine for treating gout |
| CN104352991A (en) * | 2014-11-26 | 2015-02-18 | 路晓芹 | Traditional Chinese medicine preparation for treating gout and preparation method thereof |
| CN105497797A (en) * | 2015-12-31 | 2016-04-20 | 张茂全 | Medicinal liquor for treating phlegm stagnation type gout |
| CN105664129A (en) * | 2016-04-18 | 2016-06-15 | 王芬 | Traditional Chinese medicine composition for treating gout |
-
2016
- 2016-07-17 CN CN201610558961.3A patent/CN106039113A/en active Pending
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1593589A (en) * | 2004-06-28 | 2005-03-16 | 黄资源 | Gout treating pills and preparation method thereof |
| CN1814220A (en) * | 2005-11-23 | 2006-08-09 | 安徽省药物研究所 | Medicine for treating gout and preparing method |
| CN101347605A (en) * | 2008-08-15 | 2009-01-21 | 北京和润创新医药科技发展有限公司 | Chinese medicinal composition for treating gout and preparation method and application thereof |
| CN101732498A (en) * | 2008-11-17 | 2010-06-16 | 任风辉 | Formula of Chinese medicament for treating gout |
| CN101843867A (en) * | 2009-11-04 | 2010-09-29 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating gout |
| CN102652810A (en) * | 2012-04-12 | 2012-09-05 | 王伟 | Traditional Chinese medicine composition for treating gout and preparation method of traditional Chinese medicine composition |
| CN102614431A (en) * | 2012-04-21 | 2012-08-01 | 韩合旭 | Medicament for treating gout and bone disease |
| CN103007079A (en) * | 2012-12-08 | 2013-04-03 | 张道荣 | Chinese patent medicine for treating gout |
| CN104352991A (en) * | 2014-11-26 | 2015-02-18 | 路晓芹 | Traditional Chinese medicine preparation for treating gout and preparation method thereof |
| CN105497797A (en) * | 2015-12-31 | 2016-04-20 | 张茂全 | Medicinal liquor for treating phlegm stagnation type gout |
| CN105664129A (en) * | 2016-04-18 | 2016-06-15 | 王芬 | Traditional Chinese medicine composition for treating gout |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107375769A (en) * | 2017-08-15 | 2017-11-24 | 徐琛 | A kind of Chinese prescription for being used to treat synovitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101934025B (en) | Traditional Chinese medicine for clearing away heat and toxic material | |
| CN1411830A (en) | Medicine for curing hypertension and its preparation method | |
| CN101745047A (en) | Chinese medicinal composition for treating gout disease and preparation method thereof | |
| CN102940693B (en) | Medicine composition for treating diabetic foot | |
| CN106039113A (en) | Traditional Chinese medicine prescription for treating gout | |
| CN102526275B (en) | Pharmaceutical for curing gout and preparation method thereof | |
| CN103599321B (en) | Traditional Chinese medicine composition for treating osteoporosis | |
| CN102370853A (en) | Traditional Chinese medicine for treating chronic pyelonephritis | |
| CN106039114A (en) | External traditional Chinese medicine prescription for treating gout | |
| CN102526614B (en) | Chinese medicinal kidney healing powder for treating chronic renal failure | |
| CN102008687B (en) | Chinese medicinal powder for treating talalgia | |
| CN106138868A (en) | A kind of oral medicinal herb prescription for treating gout | |
| CN101912570B (en) | Medicinal composition for treating rheumatism and preparation method thereof | |
| CN101991740A (en) | Traditional Chinese medicine preparation for treating difficult urination | |
| CN100528198C (en) | Medicine for treating gout | |
| CN104096170B (en) | External-use ultra-fine powder traditional Chinese medicine for weight loss and preparation method thereof | |
| CN102225125B (en) | Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof | |
| CN102133322A (en) | Externally-applied traditional Chinese medicine composition for treating acute gouty arthritis and preparation method thereof | |
| CN102335304B (en) | Chinese medicine composition for dispelling wind, removing dampness, invigorating blood circulation, and relieving pain and preparation method thereof | |
| CN1178681C (en) | Notoginseng and pangolin scales tinea curing pill | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN1261146C (en) | Plaster for treating hyperplasia of mammary glands | |
| CN104491703A (en) | Oral traditional Chinese medicine composition for treating traumatic synovitis of knee joint | |
| CN105435013A (en) | Traditional Chinese medicine enema powder used for treating chronic nonspecific ulcerative colitis, and preparation method thereof | |
| CN104027741A (en) | Oral traditional Chinese medicine composition capable of treating female chondromalacia patellae |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161026 |